Microarrays at Work

Photo: Jeff MillerTomas A Prolla Editor's Note: To keep up with topical research trends, LabConsumer continues to address various aspects of microarray technology in 2000. "Array of Options" (May 29, 2000) described the features of commercially available systems for arraying, scanning, and analyzing microarrays, and an upcoming issue (Sept. 4, 2000) will profile the growing variety of premade arrays for various applications. To gain further access to this burgeoning field, LabConsumer entered th

Written byAmy Francis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Photo: Jeff Miller

Tomas A Prolla

Editor's Note: To keep up with topical research trends, LabConsumer continues to address various aspects of microarray technology in 2000. "Array of Options" (May 29, 2000) described the features of commercially available systems for arraying, scanning, and analyzing microarrays, and an upcoming issue (Sept. 4, 2000) will profile the growing variety of premade arrays for various applications. To gain further access to this burgeoning field, LabConsumer entered the labs of two promising young investigators pursuing careers centered on this powerful technology.

Mere mention of the word "microarray" is enough to land papers in elite research journals and send day traders scrambling. Why all the fuss? Researchers in the field say it best: "The appeal of studying thousands of genes at the same time as opposed to focusing on one gene or pathway attracted me right from the beginning," remarks Tomas A. Prolla, assistant professor of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies